Frontiers | PTC-209 Anti-Cancer Effects Involved the Inhibition of STAT3 Phosphorylation | Pharmacology
PTC-209 | BMI-1 Inhibitor | MedChemExpress
Bmi1 inhibitor PTC-209 promotes Chemically-induced Direct Cardiac Reprogramming of cardiac fibroblasts into cardiomyocytes | Scientific Reports
Targeting of BMI-1 with PTC-209 inhibits glioblastoma development. - Abstract - Europe PMC
Frontiers | PTC-209 Anti-Cancer Effects Involved the Inhibition of STAT3 Phosphorylation | Pharmacology
Targeting of BMI-1 with PTC-209 shows potent anti-myeloma activity and impairs the tumour microenvironment | Journal of Hematology & Oncology | Full Text
BMI-1 downregulation by PTC-209 leads to an increase in H3K27me3... | Download Scientific Diagram
PTC-209 is a potent anti-myeloma agent that induces apoptosis. (A)... | Download Scientific Diagram
![PDF] The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/61dfda9a1512d58d66ac672569d4f3193a851ba9/7-Figure5-1.png "PDF] The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells | Semantic Scholar")
PDF] The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells | Semantic Scholar
![PDF] The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/61dfda9a1512d58d66ac672569d4f3193a851ba9/8-Figure7-1.png "PDF] The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells | Semantic Scholar")
PDF] The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells | Semantic Scholar
Targeting of BMI-1 with PTC-209 inhibits glioblastoma development. - Abstract - Europe PMC
PTC-209 is a Specific BMI-1 Inhibitor and Impairs the Tumor Microenvironment - Network of Cancer Research
Frontiers | PTC-209 Anti-Cancer Effects Involved the Inhibition of STAT3 Phosphorylation | Pharmacology
Concurrent targeting of BMI1 and CDK4/6 abrogates tumor growth in vitro and in vivo | Scientific Reports
The novel BMI-1 inhibitor PTC596 downregulates MCL-1 and induces p53-independent mitochondrial apoptosis in acute myeloid leukemia progenitor cells | Blood Cancer Journal
PTC-209 demonstrates on-target effects in MM via downregulation of... | Download Scientific Diagram
Epigenetic regulator BMI1 promotes alveolar rhabdomyosarcoma proliferation and constitutes a novel therapeutic target - Shields - 2021 - Molecular Oncology - Wiley Online Library
Preclinical activity of the novel B‐cell‐specific Moloney murine leukemia virus integration site 1 inhibitor PTC‐209 in acute myeloid leukemia: Implications for leukemia therapy - Nishida - 2015 - Cancer Science - Wiley Online Library
Frontiers | PTC-209 Anti-Cancer Effects Involved the Inhibition of STAT3 Phosphorylation | Pharmacology
BMI1 Inhibition Eliminates Residual Cancer Stem Cells after PD1 Blockade and Activates Antitumor Immunity to Prevent Metastasis and Relapse - ScienceDirect
BMI1 in the heart: Novel functions beyond tumorigenesis - eBioMedicine
Cancers | Free Full-Text | BMI1-Mediated Pemetrexed Resistance in Non-Small Cell Lung Cancer Cells Is Associated with Increased SP1 Activation and Cancer Stemness | HTML
Targeting of BMI-1 with PTC-209 shows potent anti-myeloma activity and impairs the tumour microenvironment | Journal of Hematology & Oncology | Full Text
